NSC population and proliferation decrease drastically during the second postnatal week of DG development. by Cristina Medina-Menéndez (21800157)

6(a) is <i>p</i> + <i>q</i> vs time; 6(b) is <i>p</i> + <i>q</i> distribution for studied data; 6(c) is <i>p</i> + <i>q</i> vs time after 2000 year; and, 6(d) is <i>p</i> + <i>q</i... by Héctor Raúl Olivares-Sánchez (13014866)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Refinement of scrambles, with no USM decreases. by Jedediah M. Singer (10331212)

Power law singularity index of (β₁) thawed sandstone under unknown β value conditions. by Liang Zhang (41392)

Modeling electrical properties of the light-insensitive membrane of <i>P</i>. <i>americana</i>. by Roman V. Frolov (9647905)

Jagged index-unmethylated (JI-U) values of ucfDNA. by Meihui Chen (1670020)

Temporal trends in large carnivore attacks on humans in different regions of the world. by Giulia Bombieri (8613945)

“…In countries with (<b>D</b>) large forest coverage, the number of attacks in the last several years has decreased. …”

<i>C</i>. <i>elegans</i> nictation ratio decreases over the course of our 30 min videos. by Patrick D. McClanahan (2385076)

Group C example; CXCL6: Temporal pattern of protein expression level (mean NPX ± 0.95 CI) for C-X-C motif chemokine ligand 6 (CXCL6) showing statistically significant late peak and increasing trend, that is day 1 < day 4 < day 10 mean NPX values (4,41 vs 6,81 vs 8,57 respectively; p<0,005). by Pavlos Vlachogiannis (12289810)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Decreased recovery times were observed after repeated handling and anesthesia sessions. by Lingzhi Wang (114519)

TITAN thresholds and percentile estimates for benthic macroinvertebrate and diatom communities deemed to be sensitive decreasers or tolerant increasers. The thresholds represent the largest fsum <i>z</i> value in the main data analysis run (i.e., the median), whereas the 5^th and 95^th percentile change points are determined from 500 bootstrap replicate runs. Sensitive taxa change points derived from decreaser sum <i>z</i>- relative to increasing impervious cover (I.C.; %), specific conductivity (SpCond; μS cm^-1), total nitrogen (TN; μg L^-1), and total phosphorus (TP; μg L^-1).... by Brent J. Bellinger (21156150)

“…Sensitive taxa change points derived from decreaser sum <i>z</i>- relative to increasing impervious cover (I.C.; %), specific conductivity (SpCond; μS cm^-1), total nitrogen (TN; μg L^-1), and total phosphorus (TP; μg L^-1). …”

Slope <i>c</i>(<i>t</i>) of sensitivity to feedback at each time step. The slope is computed on data from participants reporting different trust values (first column). by Guillaume Deffuant (130910)

Group A example; CCL4 (MIP-1ß): Temporal pattern of protein expression level (mean NPX ± 0.95 CI) for C-C motif chemokine ligand 4 (CCL4) a.k.a. macrophage inflammatory protein-1ß... by Pavlos Vlachogiannis (12289810)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)